Milrinone|cas 78415-72-2|supplier DC Chemicals

Cas No.:	78415-72-2
Chemical Name:	Milrinone
Synonyms:	milrinone;3-CYANO-6-METHYL-5-(4-PYRIDYL)-2-PYRIDONE;6-METHYL-5-(4-PYRIDYL)-2-PYRIDONE-3-CARBONITRILE;1,6-DIHYDRO-2-METHYL-6-OXO-(3,4'-BIPYRIDINE)-5-CARBONITRILE;1,6-DIHYDRO-2-METHYL-6-OXO-3,4-BIPYRIDINE-5-CARBONITRILe;1,2-DIHYDRO-6-METHYL-2-OXO-5-(4-PYRIDINYL)-NICOTINONITRILE;4’-bipyridine)-5-carbonitrile,1,6-dihydro-2-methyl-6-oxo-( win47203;Milirinone;MilrinoneUsDmf;2-METHYL-6-OXO-1,6-DIHYDRO-3,4'-BIPYRIDINE-5-CARBONITRILE(MILRINONE);1,2-DIHYDRO-6-METHYL-2-OXO-5-(4-PYRIDINYL)-NICOTINONITRILES(MILRINONE);6-Dihydro-2-methyl-6-oxo-(3,4'-bipyridine)-5-carbonitrile;2-Methyl-6-oxo-1,6-dihydro-3,4\'-bipyridine-5-carbonitrile (Milrinone);4'-BIPYRIDINE)-5-CARBONITRILE, 1,6-DIHYDRO-2-METHYL-6-OXO-(;6-methyl-2-oxo-5-pyridin-4-yl-1H-pyridine-3-carbonitrile;Win 47203;2-methyl-6-oxo-1,6-dihydro-3,4'-bipyridine-5-carbonitrile;Corotrop;Corotrope;Milrila;Milrinona;Milrinonum;Primacor;1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile;Milrinonum [Latin];Milrinona [Spanish];YM 018;Milrinone(Primacor);WIN 47203-2;2-methyl-6-oxo-1,6-dihydro-[3,4'-bipyridine]-5-carbonitrile;1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile
SMILES:	O=C1C(C#N)=C([H])C(C2C([H])=C([H])N=C([H])C=2[H])=C(C([H])([H])[H])N1[H]
Formula:	C₁₂H₉N₃O
M.Wt:	211.2194
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Description:

For the detailed information about the solubility of Milrinone in water, the solubility of Milrinone in DMSO, the solubility of Milrinone in PBS buffer, the animal experiment（test） of Milrinone, the in vivo,in vitro and clinical trial test of Milrinone, the cell experiment（test） of Milrinone, the IC50, EC50 and Affinity of Milrinone , please contact DC Chemicals.

MSDS

COA

LOT NO.	DOWNLOAD

2018-0101
2018-0101

Cat. No.	Product name	Field of application
DC73764	CRD733	CRD733 (ASP4901) is a potent, selective cGMP-specific PDE9 (phosphodiesterase 9) inhibitor.
DC70239	BAY 2666605	BAY2666605 is a potent, small molecule PDE3A-SLFN12 complex inducer with EC50 of 7 nM.BAY2666605 triggers the formation of a complex of two proteins called SLFN12 and PDE3A. This complex drive cancer cells into cell death by a mechanism called apoptosis.
DC48226	ONO-8430506	ONO-8430506 is an orally bioavailable and potent autotaxin (ATX)/ENPP2 inhibitor with the IC90 of 100 nM for ATX activity in mouse plasma.
DC47989	FPFT-2216	FPFT-2216, a “molecular glue” compound, degrades phosphodiesterase 6D (PDE6D), zinc finger transcription factors Ikaros (IKZF1), Aiolos (IKZF3), and casein kinase 1α (CK1α). FPFT-2216 can be used for the research of cancer and inflammatory disease.
DC42521	MBCQ	MBCQ is a potent and selective the type V phosphodiesterase (PDE V; PDE5) inhibitor with an IC50 of 19 nM. MBCQ has IC50s >100 µM for PDE1, PDE2, PDE3, and PDE4, respectively. MBCQ dilates coronary arteries via potent and specific inhibition of cGMP-PDE.
DC40977	DSR-141562	DSR-141562 is a novel, orally active, and selective brain-penetrant phosphodiesterase 1 (PDE1) inhibitor. DSR-141562 shows preferential selectivity for human PDE1B with an IC50 of 43.9 nM, and the IC50 values for human PDE1A and 1C are 97.6 and 431.8 nM, respectively. DSR-141562 can be used for the study of positive symptoms, negative symptoms and cognitive impairments associated with schizophrenia.
DC40378	MR-L2	MR-L2 is a reversible and noncompetitive allosteric activator of long-isoform phosphodiesterase-4 (PDE4), activates representative PDE4 long-isoform variants (PDE4A4, PDE4B1, PDE4C3, PDE4D5). MR-L2 suppresses PGE2-induced MDCK cell cyst formation with an EC50 of 1.2 μM.
DC28354	(E/Z)HA-155	(E/Z)HA-155 is a potent and selective autotaxin (ATX) inhibitor with an IC50 of 5.7 nM.
DC5901	Tadalafil	Tadalafil is a potent and selective inhibitor of Phosphodiesterase-5 (PDE5) This compound prevents the breakdown of phosphodiesterases, many of which are used as secondary messengers. By preventing the breakdown of these messenger molecules, tadalafil can
DC11937	PF 05180999	PF-05180999 (PF 5180999) is a potent, selective, brain-penetrating and orally bioavailable phosphodiesterase 2A (PDE2A) inhibitor with IC50 of 1 nM.